Quince Therapeutics, Inc. (QNCX): SC 13G filed Dec 15, 2023

Form type

SC 13G

Filing date

Dec 15, 2023

Accession number

0001140361-23-057682

Filer

Quince Therapeutics, Inc. (CIK 1662774)